| "Streptomyces venezuelae subsp. roseospori" (sic) Falcao de Morais et al. 1958| AS 4.1656| ATCC 19753| ATCC 23958 [[Streptomyces roseosporus]]| BCRC 13644| BCRC 13771 [[Streptomyces roseosporus]]| CBS 492.68| CBS 941.68 [[Streptomyces roseosporus]]| CCRC 13644| CCRC:13644| CGMCC 4.1871 [[Streptomyces roseosporus]]| CGMCC 4.2073 [[Streptomyces roseosporus]]| DSM 40022| DSM 40122 [[Streptomyces roseosporus]]| HAMBI 1010| IFM 1180| IFO 12767| IFO 12910 [[Streptomyces roseosporus]]| IMET 43562| ISP 5022| ISP 5122 [[Streptomyces roseosporus]]| JCM 4122| JCM 4412 [[Streptomyces roseosporus]]| JCM 4576| KCTC 9568 [[Streptomyces roseosporus]]| NBRC 12767| NBRC 12910 [[Streptomyces roseosporus]]| NCIMB 13008 [[Streptomyces roseosporus]]| NCIMB 13018| NRRL B-2114| NRRL B-5411 [[Streptomyces roseosporus]]| NRRL-ISP 5022| RIA 1034| RIA 1125 [[Streptomyces roseosporus]]| strain 4192 [[Streptomyces roseosporus]]| strain AS 4.1871 [[Streptomyces roseosporus]]| Streptomyces filamentosus| Streptomyces filamentosus Okami and Umezawa 1953 (Approved Lists 1980) emend. Lanoot et al. 2004| Streptomyces roseisporus| Streptomyces roseosporus| Streptomyces roseosporus Falcao de Morais and Dalia Maia 1961 (Approved Lists 1980)| Streptomyces venezuelae subsp. roseospori| UNIQEM 140| VKM Ac-1266
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.04 | 0 | 1 | 1 | 1 | 1 | 1 | 0 %ile | 99 %ile | |||||
biomesight | 0.17 | 10 | 40 | 0 | 47 | 22.5 | 20 | 12.6 | 10 | 40 | 16.7 %ile | 66.7 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 0.14 % | 0.002 % | 0.001 % | 4.0 | 2864 |
CerbaLab | 33.333 % | 0 % | % | 1.0 | 3 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.